Clinical management, differential diagnosis, follow-up and biomarkers of infertile men with nonobstructive azoospermia
Hossein Azizi,Danial Hashemi Karoii,Thomas Skutella
DOI: https://doi.org/10.21037/tau-23-485
2024-02-29
Translational Andrology and Urology
Abstract:Hossein Azizi 1#^ , Danial Hashemi Karoii 1,2#^ , Thomas Skutella 3 1 Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran; 2 Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran; 3 Institute for Anatomy and Cell Biology, Medical Faculty, University of Heidelberg, Heidelberg, Germany # These authors contributed equally to this work. ^ ORCID: Hossein Azizi, 0000-0001-8246-595X; Danial Hashemi Karoii, 0000-0001-6456-1200. Comment on: Flannigan R, Tadayon Najafabadi B, Violette PD, et al . 2023 Canadian Urological Association guideline: Evaluation and management of azoospermia. Can Urol Assoc J 2023;17:228-40. Keywords: Azoospermia; infertility; guideline; management Submitted Sep 22, 2023. Accepted for publication Jan 11, 2024. Published online Feb 26, 2024. doi: 10.21037/tau-23-485 To make well-informed healthcare choices and recommendations in the management of nonobstructive azoospermia (NOA), the GRADE EtD (Grading of Recommendations Assessment, Development, and Evaluation evidence to decision) framework was applied to three specific clinical circumstances. For detailed explanations of each recommendation, see "Management of azoospermia" (1). Do surgically retrieved sperm cryopreserved duringin vitrofertilization-intracytoplasmic sperm injection (IVF-ICSI) result in lower live birth rates than fresh sperm and oocytes among males with NOA? In most couples with NOA and subsequent IVF-ICSI, cryopreservation of surgically retrieved sperm is recommended (conditional recommendation, very low certainty of evidence). How does varicocele repair before surgical sperm retrieval and IVF-ICSI affect live birth rates in men with testicular failure and a varicocele? For most couples with testicular failure and a varicocele, we recommend observation of varicoceles rather than pretreatment with varicocelectomy (conditional recommendation, low certainty of evidence). When compared to conservative management, does neoadjuvant hormonal therapy improve IVF-ICSI live birth rates among males with testicular failure NOA? Azoospermia, the absence of sperm in the ejaculate, is a significant challenge in reproductive medicine, affecting approximately 1% of the male population and 10–15% of men who seek infertility treatment (2). It can be categorized as either obstructive or nonobstructive, with distinct paths for evaluation and management. A conditional recommendation with very low certainty of evidence is not made for neoadjuvant hormone therapy in males with testicular failure NOA (3). Based on the available evidence, a conditional recommendation cannot be made for neoadjuvant hormone therapy in males with testicular failure NOA. The certainty of evidence supporting this recommendation is very low. Testicular failure NOA is a condition characterized by the absence of sperm in the ejaculate due to testicular dysfunction. Neoadjuvant hormone therapy, which involves the administration of hormones before a medical intervention, is sometimes considered a treatment option for this condition. However, the current evidence regarding the effectiveness and safety of neoadjuvant hormone therapy in males with testicular failure NOA is limited and of very low certainty. This means the available studies have significant limitations, such as small sample sizes, lack of long-term follow-up, and inconsistent results. Due to the lack of high-quality evidence, it is not possible to make a definitive recommendation regarding the use of neoadjuvant hormone therapy in this population. Additional research with larger sample sizes and rigorous study designs is needed to understand better the potential benefits and risks associated with this treatment approach (4). In summary, based on the current evidence, a conditional recommendation with very low certainty of evidence is not made for neoadjuvant hormone therapy in males with testicular failure NOA. Healthcare providers and patients need to consider the limitations of the available evidence when making treatment decisions for this condition. For patients with obstructive azoospermia, surgical interventions may be considered. Options include vasovasostomy or vasoepididymostomy to restore sperm flow. The choice of procedure depends on the site and extent of obstruction. The initial step in managing obstructive azoospermia involves a thorough diagnostic evaluation to identify the underlying cause. This includes a detailed medical history, physical examination, and laboratory tests. Semen analysis, hormonal assessment, genetic testing, and imaging studies such as scrotal ultrasound and magnetic resonance imaging (MRI) may be performed to determine the location and extent of the obstruction. The management of obstr -Abstract Truncated-
urology & nephrology,andrology